Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Employers have largely attempted to avoid these cost increases, with a 2023 Accolade survey finding that approximately 60% of employers do not intend to cover GLP-1s in 2024
Other Uses: Often incorporated into body recomposition or cutting protocols when patients want fat loss support without appetite suppression, hormonal disruption, or nervous system stimulation
The US prescribing information for tirzepatide carries a black box warning for the risk of thyroid C-cell tumors
Connect with Wolters Kluwer Join Our Talent Community We'll keep you updated
Which one fits you is a decision we make together at your evaluation
doi:10.3945/an.112.002535
US$ 26.60
US$ 21.73
US$ 26.47
US$ 24.04
US$ 26.72
US$ 28.21
US$ 23.68
